All In Biotech

Drug Trial Radar · NCT05292586

A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

A 12 Week, Randomized, Double-blind, Multicenter, Active Controlled, 2-Arm Parallel Group Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose (Fixed Combination of Extrafine Beclomethasone Dipropionate Plus Formoterol Fumarate) Compared to CHF 718 pMDI 800µg Total Daily Dose (Extrafine Beclomethasone Dipropionate) in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

Last checked: Nov 19, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,377 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,377

Actual

Start

Aug 31, 2022

Primary completion

Jun 24, 2024

Study completion Jun 24, 2024

Sponsor

Lead sponsor
Chiesi Farmaceutici S.p.A.Industry
Sponsor type
Industry
First posted
Mar 23, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Compare the superiority of CHF 1535 versus CHF 718 in subjects with asthma who are on medium or high dose inhaled corticosteroids.

Conditions

  • Asthma

Interventions

  • Beclomethasone Dipropionate/Formoterol FumarateDrug

    Available in pressurized inhalation solution BDP/FF 200/6 µg

  • Beclomethasone DipropionateDrug

    Available in pressurized inhalation solution BDP 100 µg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 1_Change From Baseline in FEV1 AUC0-12h Normalised by Time at Week 12Time frame: Baseline (pre-dose on Week 0) and Week 12.

Locations

91 sites in 1 country. Site status is shown where the registry gives one.

  • Chiesi Clinical Trial Site 840858

    Mobile, Alabama

  • Chiesi Clinical Trial Site 840895

    Chandler, Arizona

  • Chiesi Clinical Trial Site 840856

    Encinitas, California

  • Chiesi Clinical Trial Site 840843

    Huntington Beach, California

  • Chiesi Clinical Trial Site 840860

    Huntington Beach, California

  • Chiesi Clinical Trial Site 840896

    Long Beach, California

  • Chiesi Clinical Trial Site 840883

    Los Angeles, California

  • Chiesi Clinical Trial Site 840810

    Los Angeles, California

  • Chiesi Clinical Trial Site 840869

    Newport Beach, California

  • Chiesi Clinical Trial Site 840890

    North Hollywood, California

  • Chiesi Clinical Trial Site 840808

    Northridge, California

  • Chiesi Clinical Trial Site 840879

    Pomona, California

  • Chiesi Clinical Trial Site 840868

    Sacramento, California

  • Chiesi Clinical Trial Site 840849

    San Diego, California

  • Chiesi Clinical Trial Site 840877

    San Diego, California

  • Chiesi Clinical Trial Site 840861

    San Jose, California

  • Chiesi Clinical Trial Site 840881

    Westminster, California

  • Chiesi Clinical Trial Site 840873

    Colorado Springs, Colorado

  • Chiesi Clinical Trial Site 840800

    Denver, Colorado

  • Chiesi Clinical Trial Site 840820

    Coral Gables, Florida

  • Chiesi Clinical Trial Site 840841

    Cutler Bay, Florida

  • Chiesi Clinical Trial Site 840817

    Greenacres City, Florida

  • Chiesi Clinical Trial Site 840822

    Hialeah, Florida

  • Chiesi Clinical Trial Site 840838

    Hialeah, Florida

  • Chiesi Clinical Trial Site 840864

    Kissimmee, Florida

  • Chiesi Clinical Trial Site 840814

    Miami, Florida

  • Chiesi Clinical Trial Site 840819

    Miami, Florida

  • Chiesi Clinical Trial Site 840875

    Miami, Florida

  • Chiesi Clinical Trial Site 840887

    Miami, Florida

  • Chiesi Clinical Trial Site 840821

    Miami, Florida

  • Chiesi Clinical Trial Site 840829

    Miami, Florida

  • Chiesi Clinical Trial Site 840828

    Miami, Florida

  • Chiesi Clinical Trial Site 840847

    Miami, Florida

  • Chiesi Clinical Trial Site 840818

    Miami, Florida

  • Chiesi Clinical Trial Site 840802

    Miami, Florida

  • Chiesi Clinical Trial Site 840835

    Miami, Florida

  • Chiesi Clinical Trial Site 840806

    Miami, Florida

  • Chiesi Clinical Trial Site 840855

    Miami, Florida

  • Chiesi Clinical Trial Site 840809

    Miami Gardens, Florida

  • Chiesi Clinical Trial Site 840863

    Miami Lakes, Florida

Showing 40 of 91 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.